New antimicrobial agents as therapy for resistant gram-positive cocci.
about
Antimicrobial photodynamic therapy in the non-surgical treatment of aggressive periodontitis: microbiological profile.Telavancin: a novel semisynthetic lipoglycopeptide agent to counter the challenge of resistant Gram-positive pathogensWaves of resistance: Staphylococcus aureus in the antibiotic era.Efficacy of topically delivered moxifloxacin against wound infection by Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus.In vitro and in vivo activities of linezolid alone and combined with vancomycin and imipenem against Staphylococcus aureus with reduced susceptibility to glycopeptidesCharacteristic of Enterococcus faecium clinical isolates with quinupristin/dalfopristin resistance in China.Bilateral sternoclavicular joint septic arthritis secondary to indwelling central venous catheter: a case reportCurrent challenges in treating MRSA: what are the options?Vancomycin resistance: are there better glycopeptides coming?The treatment of diabetic foot infections: focus on ertapenem.Treatment strategies for central venous catheter infections.Invasive community-associated MRSA infections: epidemiology and antimicrobial management.Therapeutic potential of FtsZ inhibition: a patent perspective.Ceftaroline fosamil: a novel broad-spectrum cephalosporin with activity against methicillin-resistant Staphylococcus aureus.Predicting and preventing antimicrobial resistance utilizing pharmacodynamics: Part I gram positive bacteria.Prevalence and antimicrobial resistance pattern of methicillin resistant Staphylococcus aureus (MRSA) strains isolated from clinical specimens in Ardabil, Iran.Activities of Omadacycline and Comparator Agents against Staphylococcus aureus Isolates from a Surveillance Program Conducted in North America and Europe.Exometabolome analysis identifies pyruvate dehydrogenase as a target for the antibiotic triphenylbismuthdichloride in multiresistant bacterial pathogens.Clinico-microbiological study of Pseudomonas aeruginosa in wound infections and the detection of metallo-β-lactamase production.Intensive Care Infection Score--A new approach to distinguish between infectious and noninfectious processes in intensive care and medicosurgical patients.Distribution of genes encoding MSCRAMMs and Pili in clinical and natural populations of Enterococcus faecium.In vitro activity of TD-1792, a multivalent glycopeptide-cephalosporin antibiotic, against 377 strains of anaerobic bacteria and 34 strains of Corynebacterium speciesIn Vitro Antibacterial and Antibiotic Resistance Modifying Effect of Bioactive Plant Extracts on Methicillin-Resistant Staphylococcus epidermidis.Mode of action of Van-M-02, a novel glycopeptide inhibitor of peptidoglycan synthesis, in vancomycin-resistant bacteria.Monte Carlo simulation analysis of ceftobiprole, dalbavancin, daptomycin, tigecycline, linezolid and vancomycin pharmacodynamics against intensive care unit-isolated methicillin-resistant Staphylococcus aureus.
P2860
Q31003474-3A881635-D095-49A1-81C6-733E16F6333EQ33788308-6C1867F0-51D8-41C9-B4BD-4705B86DEFBFQ33854398-81EFDA5B-69E2-4FCC-A502-D4FE2D031437Q34932409-AB7A00DF-486C-4E79-AC30-1F208940AC0CQ35083990-DFE26C1E-A61B-4EFD-B711-DA83C982FAA8Q36171201-AC114439-75E2-4811-A843-0A06179B448BQ37150479-6B475789-F5D6-4E1B-8B3A-9D84A6786BC3Q37291338-881E89A4-E8ED-4AC4-AAAE-241B29F6B602Q37340562-804AA7F3-012C-4C4E-A368-2F41445B2156Q37458910-5375EA25-3B21-413E-960C-3D30B06BBA49Q37596412-E2EF57D4-9966-4AA6-B2B6-6AB9900D6ED5Q37800939-D60F0D42-67F9-436A-816E-DDC968D32A89Q37854070-37482E67-4C77-487B-B5B7-E09EAA9357D5Q37947221-47630423-B69A-4DE8-B4DB-BCDA8313DC36Q38692072-C1A895B9-B6EA-4E4C-97B5-02CDBFFE087BQ39520278-B0E0C285-0E10-4511-AB70-89E2D0E03C7DQ40403783-E4994DAB-59B7-41EF-BF2A-5F5F753BC061Q40734183-3ED1F84B-5294-4117-810E-7D3AA8314372Q40931739-F49B263E-8EF5-48F8-AC6A-9868D1EE873DQ41104487-6C1B6142-76E3-441E-8F49-BC85F0DDA7CCQ41914589-E4DEB896-2A07-4A1A-9FC7-6669DD0B9D11Q41954865-0AB1C3E4-803E-46B1-93EB-55B0DFC42CE7Q41965824-AFEB9623-DF44-4E2C-85BE-4ED867F9BACFQ42111453-BEB29DA7-C058-4817-9996-975028B46D5EQ46255695-D1457093-8F7E-4C1D-B0C2-66DFAE104228
P2860
New antimicrobial agents as therapy for resistant gram-positive cocci.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
New antimicrobial agents as therapy for resistant gram-positive cocci.
@en
type
label
New antimicrobial agents as therapy for resistant gram-positive cocci.
@en
prefLabel
New antimicrobial agents as therapy for resistant gram-positive cocci.
@en
P2093
P2860
P1476
New antimicrobial agents as therapy for resistant gram-positive cocci.
@en
P2093
P2860
P2888
P356
10.1007/S10096-007-0389-Y
P577
2008-01-01T00:00:00Z